奥米克朗的分子流行病学CH.1.1 血统:基因组和表型数据视角
Yasir Mohammed A Al Qurashi1, Jawaher A Abdulhakim1, Samia S Alkhalil2
1Department of Medical Laboratory, College of Applied Medical Sciences, Taibah University, Yanbu, SAU.
Cureus
|March 5, 2024
概括
奥米克朗亚型CH.1.1显示出显著的增长优势,预计将在几个国家占主导地位. 它的突变可能会增加传染性和免疫逃避,需要持续监测SARS-CoV-2的演变.
科学领域:
- 病毒学 病毒学
- 基因组学就是基因组学.
- 流行病学 流行病学
背景情况:
- SARS-CoV-2的Omicron变种 (B.1.1.529系) 由于其高传染性和免疫抵抗性,构成了全球健康挑战.
- 特别令人担忧的是BA.2.75和新出现的CH.1.1系,CH.1.1由与增加的致病性和传播相关的S:L452R突变区分开来.
- 首次在印度发现的CH.1.1,已经在全球传播,需要紧急跟踪和分析.
研究的目的:
- 分析SARS-CoV-2 CH.1.1血统的基因组和地理分布.
- 评估CH.1.1成为主导传播血统的潜力.
- 研究特定氨基酸变异对CH.1.1特征的影响.
主要方法:
- 对CH.1.1的基因组和地理分布数据来源于GISAID,PANGOLIN,Cov-Spectrum和NextStrain. 这两种病毒的基因组和地理分布数据均来自GISAID,PANGOLIN,Cov-Spectrum和NextStrain. 这两种病毒的基因组和地理分布数据均来自GISAID,PANGOLIN,Cov-Spectrum和NextStrain.
- 由于流行病学和基因组数据有限,从PubMed和ScienceDirect获得了谱系变异的表型数据.
- 分析的氨基酸变异包括S:R346T,S:K444T,S:L452R和S:F486S.
主要成果:
- 流行病学数据表明,CH.1.1具有32%的增长优势,这表明英国,新西兰,澳大利亚和美国的潜在主导地位.
- 检测到的CH.1.1病例数量从13,231例 (2023年1月21日) 增加到23,181例 (2023年2月6日),支持其增长优势.
- 在CH.1.1中氨基酸变异与增加的病毒传播能力和免疫逃避有关.
结论:
- 预计新发现的CH.1.1血统病例将大幅增加.
- 观察到的增长优势和不断增加的病例数量支持CH.1.1成为主导血统的潜力.
- 氨基酸变异可能有助于增加ACE2受体亲和力和免疫逃避,增强病毒的传播能力.
关键词:
ba.2.75 这是一个很好的例子.ch.1.1 血统 血统 血统 血统 血统s: f486ss 的时间s: k444ttt 的时间.标签:l452rr 在线s: r346ttt: r346tt: r346tt: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r346t: r更多相关视频
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.2K
08:03Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
Published on: December 7, 2021
2.2K
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Genomics
36.3K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.3K
Evolutionary Relationships through Genome Comparisons
5.7K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
5.7K
